glucotrack.com - רווח החברה לפני מסים, ריבית ופחת GCTK

Growing demand for painless glucose monitoring is expanding the target audience, where GlucoTrack, Inc. (GCTK) leads in the development of ultrasonic sensors and software. The organization's overall EBITDA demonstrates liquidity inflows from core operations, with the 0.00 level serving as a critical benchmark. Business resilience is based on a US research and development foundation and robust patent protection within the diabetes care sector.

This metric measures cash flow from operating activities before depreciation, interest, and taxes, reflecting the ability of GlucoTrack, Inc. (GCTK) to generate internal resources for growth. The trend in EBITDA demonstrates the resilience of the operating model against FDA certification delays and competition from market leaders amid high borrowing costs.